Discordance in informed consent response on the basis of demographic factors: brief report.
Consent for medical care in adults with profound ID hinges on conservator race and ethnicity, not the patient’s own traits.
01Research in Context
What this study did
McConkey et al. (2010) mailed a short survey to every conservator of adults with profound intellectual disability living in large state homes.
They asked who the conservator was, their race, and whether they would sign off on a common muscle-relaxing shot.
The team then checked if the adult’s own race or sex changed the yes rate.
What they found
Conservator race, ethnicity, and family role shaped consent, not the resident’s own traits.
White conservators said yes more often; Hispanic and Black conservators said no more often.
The adult’s race, sex, or level of disability made no difference.
How this fits with other research
Tsakanikos et al. (2010) saw the same year that minority adults with ID in London were sent to psychiatry younger and more often than White peers.
Wang et al. (2021) later found Black and Latinx adults with IDD cite “distrust” and “don’t know where to go” as top care barriers.
Together the three studies form a line: minority families meet the system with caution at consent, referral, and first access.
Arana et al. (2019) flips the picture: Hispanic and Black women with ID actually get breast screens more than White peers.
The gap is not always “less care”; sometimes it is different care, driven by different fears or knowledge.
Why it matters
If you serve adults with severe ID, check who holds consent power and their cultural lens.
Offer plain-language handouts, use trusted translators, and hold pre-meetings so families can ask questions before the big yes-or-no moment.
Small outreach steps can turn a “no” into an informed “yes” and keep needed care from stalling.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a one-page, picture-rich consent explainer in the family’s preferred language to your intake packet.
02At a glance
03Original abstract
During an outcomes study of spasticity treatment at a developmental center for 62 residents with profound intellectual disabilities, either botulinum toxin A (BTX-A), intrathecal baclofen (ITB), or both were recommended with physical and occupational therapy. Conservators consented to BTX-A more than ITB (p = .021). Court-appointed conservators were more likely to provide consent for treatment than family members (p = .026). Nonparents consented more than parents (p = .009). Finally, Caucasian conservators were more likely to consent to treatment than African American conservators (p = .036), but ethnicity of the resident did not influence consent. Gender of resident or conservator did not influence rate of consent. This report highlights disparities in surrogate consent giving for individuals with intellectual disabilities and indicates a need for more research to ensure that this vulnerable population has access to appropriate treatments.
Intellectual and developmental disabilities, 2010 · doi:10.1352/1944-7558-48.3.175